Galderma Group AG - Company Profile
Powered by 
All the sales intelligence you need on Galderma Group AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Galderma Group AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Galderma Group AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
- Top 10 Big Medical Companies in Europe in 2021 by Revenue
Galderma Group AG Catalyst Calendar
Proactively evaluate Galderma Group AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Galderma Group AG Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Nov 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 31 Oct 2019 | Phase II Trial Initiation | Galderma SA | - | Sculptra | Dermatology | Unspecified Dermatological Disorders | Clinical Trial Registry |
| 30 Sep 2019 | Phase II Trial Completion | Galderma SA | - | Perlane-L; Restylane Defyne; Restylane Volyme | Dermatology | Unspecified Dermatological Disorders | Clinical Trial Registry |
| 30 Sep 2019 | Phase III Trial Initiation | Galderma SA; PPD Inc; Syneos Health Inc | SYNH | methyl aminolevulinate hydrochloride | Dermatology | Actinic (Solar) Keratosis | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer